Core Insights - Royal Philips has launched Transcend Plus, an advanced cardiovascular ultrasound system that enhances image quality and integrates artificial intelligence to support clinicians in cardiac care [2][3][5]. Product Advancements - Transcend Plus features significant improvements in 2D and 3D imaging quality, with FDA-cleared enhancements that provide superior visualization of cardiac anatomy and function [5][7]. - The system includes 26 FDA-cleared AI applications, the most in the industry, designed to streamline clinical workflows and improve diagnostic accuracy across various care settings [7][9]. Clinical Impact - The new 2D Auto EF Advanced feature expands AI capabilities for contrast images, crucial for assessing cardiac function, and minimizes operator variability for more reliable measurements [5][8]. - Transcend Plus supports left ventricular function assessment, a critical application in cardiac imaging, enabling quick and consistent evaluations across different patients [8][9]. Operational Efficiency - The system is designed to help cardiology teams manage increasing patient volumes and clinical complexities while maintaining high diagnostic quality [2][9]. - Transcend Plus delivers enhanced image quality, advanced AI integration, and faster insights, which collectively support timely, evidence-based clinical decisions [9]. Market Position - Philips is positioned as a leader in health technology, with a strong focus on innovation in diagnostic imaging and ultrasound, generating EUR 18 billion in sales in 2024 [12].